Skip to main content
. 2022 Feb 22;7:67–77. doi: 10.1016/j.jdin.2022.02.006

Table IV.

Prevalence of androgenetic alopecia among men and women with severe COVID-19

Study Prevalence of AGA in patients with severe COVID-19
Men
 Goren et al,14 2020 70.7% (29/41)
 Lee et al,16 2020 73.5% (247/336)
 Salazar et al,33 2021 91.4% (32/35)
 Torabi et al,42 2021 73.8% (45/61)
 Wambier et al,45 2020 78.7% (96/122)
 Total 75.5% (449/595)
Women
 Torabi et al,42 2021 56.1% (32/57)
 Wambier et al,45 2020 41.5% (22/53)
 Total 49.1% (54/110)

AGA, Androgenic alopecia.